EXANE DERIVATIVES - TWIST BIOSCIENCE CORP ownership

TWIST BIOSCIENCE CORP's ticker is TWST and the CUSIP is 90184D100. A total of 200 filers reported holding TWIST BIOSCIENCE CORP in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of TWIST BIOSCIENCE CORP
ValueSharesWeighting
Q1 2022$177,362,000
-54.2%
3,592
-0.9%
0.05%
-46.2%
Q3 2021$387,538,000
-11.1%
3,6230.0%0.09%
-6.1%
Q2 2021$435,764,000
+109.6%
3,623
+115.8%
0.10%
+67.8%
Q1 2021$207,952,0001,6790.06%
Other shareholders
TWIST BIOSCIENCE CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Tao Capital Management LP 828,815$110,440,00025.34%
Casdin Capital, LLC 1,000,000$133,250,0003.38%
BRANDYWINE MANAGERS, LLC 17,403$2,319,0002.64%
Capital Impact Advisors, LLC 45,154$6,017,0001.94%
Nicholas Investment Partners, LP 182,967$24,380,0001.53%
Lombard Odier Asset Management (Switzerland) SA 196,676$26,207,0001.33%
Nikko Asset Management Americas, Inc. 2,524,602$325,371,0001.27%
ARK Investment Management 5,054,864$673,561,0001.25%
Jackson Square Partners, LLC 1,307,237$174,189,0001.00%
Intellectus Partners, LLC 28,058$3,739,0000.84%
View complete list of TWIST BIOSCIENCE CORP shareholders